Beyond labels: potential and challenges of AI for improved diagnostics and treatment in neuropsychiatry

<h3>Biography</h3> Joseph Kambeitz is a researcher, psychiatrist and psychologist with a focus on prevention and prediction for psychological disorders. He studied psychology and medicine at the University of Munich in Germany and was trained as a psychiatrist at the University of Munich. Since 2019 he works at the University of Cologne where he is head of an outpatient unit and leads an interdisciplinary research group. He serves as a vice director of the department of psychiatry. In his research Joseph Kambeitz focuses on developing AI-based tools that can improve diagnosis and treatment in neuropsychiatry as well as on computational methods to identify neurobiological mechanisms underlying brain disorders. Neuropsychiatric disorders are marked by significant heterogeneity in symptom manifestation and disease progression. Emerging artificial intelligence (AI) technologies offer promising solutions for unraveling this complexity, enabling tailored patient treatments. AI-based methodologies are poised to revolutionize the identification of novel patient subgroups within broad diagnostic categories, enhancing our understanding of these conditions. Preliminary research underscores AI’s potential while also drawing attention to current limitations, including the restricted applicability of existing models across diverse patient populations. Critical issues yet to be addressed encompass the ethical implications of deploying AI tools in healthcare and the challenges of integrating these technologies into clinical practice. Among the most recent advancements is the exploration of innovative biomarkers, such as linguistic patterns, and the integration of advanced language models for clinical diagnostics and therapy. This development signifies a pivotal step towards leveraging AI for more nuanced and effective approaches to neuropsychiatric care.